腹腔透析患者心血管事件的风险预测
Liang Liu1, Liu Zhang2, Daohai Zhang1
1Department of Nephrology, Chongqing Key Laboratory of Prevention and Treatment of Kidney Disease, Chongqing Clinical Research Center of Kidney and Urology Diseases, Xinqiao Hospital, Army Medical University (Third Military Medical University), Chongqing, 400037, China.
BMC nephrology
|April 5, 2025
概括
心血管事件是腹膜透析患者的主要关注点. 一个机器学习模型有效地使用12个关键变量预测这些事件,帮助早期干预.
科学领域:
- 腎病學和心血管醫學.
- 医疗保健中的人工智能
- 临床环境中的预测分析.
背景情况:
- 心血管事件 (CVEs) 是腹腔透析 (PD) 患者的主要死亡原因,占死亡率的近40%.
- 早期识别患有CVE高风险的患者对于降低死亡率和改善患者的治疗结果至关重要.
- 机器学习提供了一种强大的方法来识别临床数据中的复杂模式,以便在PD患者中准确预测CVE.
研究的目的:
- 开发和验证一种机器学习模型,用于预测腹腔透析 (PD) 患者的心血管事件 (CVEs).
- 确定在PD患者群体中最能预测CVE的关键临床变量.
- 为医疗保健提供者创建一个实用的工具,以促进高风险PD患者的积极干预.
主要方法:
- 分析了251名PD患者的队列,另有42名用于外部验证.
- 拉索回归将37个初始变量减少到25个. 评估了6个机器学习算法,XGBoost被选为最佳模型.
- 最终的XGBoost模型使用了12个选定的变量,并被内部和外部验证. 开发了一个Web应用程序.
主要成果:
- 在5倍交叉验证过程中,XGBoost模型实现了0.94的AUC.
- 一个简化的12个变量模型显示出强大的预测性能 (AUC0.88内部,0.78外部).
- 关键预测因素包括导管时的年龄,身高,HDL,性别和血红蛋白. 年龄较大,身高较低,男性性别,高HDL和低血红蛋白与增加的CVE风险有关.
结论:
- 一个12变量机器学习模型有效预测腹膜透析患者的心血管事件.
- 开发的模型可以提前识别高风险个体,促进及时干预.
- 预测模型已经成功地集成到一个用户友好的临床应用的Web应用程序中.
相关概念视频
01:27Dialysis
237
Renal failure occurs when the kidneys lose their ability to filter waste products from the blood effectively. It can be classified into two types: acute renal failure (ARF) and chronic renal failure (CRF).
Acute kidney injury develops suddenly and can be caused by pre-renal causes (e.g., hypovolemia, shock), intrinsic renal causes (e.g., acute tubular necrosis), or post-renal causes (e.g., urinary obstruction). In contrast, chronic renal failure progresses gradually over time and is often...
Acute kidney injury develops suddenly and can be caused by pre-renal causes (e.g., hypovolemia, shock), intrinsic renal causes (e.g., acute tubular necrosis), or post-renal causes (e.g., urinary obstruction). In contrast, chronic renal failure progresses gradually over time and is often...
237
01:22Heart Failure Drugs: Diuretics
298
Heart failure and kidney perfusion are interconnected in a complex way. Reduced renal perfusion and venous congestion are two significant factors that contribute to renal dysfunction in heart failure. The kidneys, primarily responsible for fluid balance in the body, are adversely affected due to compromised cardiac output and increased venous pressure. In response to reduced renal perfusion, the kidneys activate neurohumoral mechanisms to restore balance. However, these mechanisms can be...
298
01:11Renal Failure: Dose Adjustments
46
In patients with renal impairment, drugs undergo significant changes in their pharmacokinetics, which require dosage adjustments to ensure safe and effective therapy.
Reduced renal clearance and elimination rate are common outcomes of renal impairment. These alterations lead to a prolonged elimination half-life and an altered apparent volume of distribution for drugs. As a result, dosage adjustments are typically necessary to maintain optimal drug levels in the body.
However, dosage adjustments...
Reduced renal clearance and elimination rate are common outcomes of renal impairment. These alterations lead to a prolonged elimination half-life and an altered apparent volume of distribution for drugs. As a result, dosage adjustments are typically necessary to maintain optimal drug levels in the body.
However, dosage adjustments...
46
01:17Factors Affecting Renal Clearance: Renal Impairment
37
Renal dysfunction significantly impairs the renal clearance of drugs, leading to potential complications in drug therapy. Renal failure, which can be caused by various factors, poses a significant challenge in the elimination of drugs from the body.
One condition associated with renal failure is uremia. Uremia is characterized by impaired glomerular filtration and fluid accumulation in the body. This condition hinders the renal clearance of drugs, resulting in drug accumulation and potential...
One condition associated with renal failure is uremia. Uremia is characterized by impaired glomerular filtration and fluid accumulation in the body. This condition hinders the renal clearance of drugs, resulting in drug accumulation and potential...
37
01:19Blood Studies for Cardiovascular System II: CRP, Hcy, and Cardiac Natriuretic Peptide Markers
39
Cardiac biomarkers are critical in diagnosing, prognosing, and managing cardiovascular diseases. Routine measurement of specific biomarkers such as B-type natriuretic peptide (BNP), C-reactive protein (CRP), and homocysteine (Hcy) is common practice in clinical settings to evaluate heart function and predict cardiovascular events.
These markers indicate stress or strain on the heart muscle:
Natriuretic Peptides (BNP)
Cardiac myocytes produce these hormones in response to ventricular stretching...
These markers indicate stress or strain on the heart muscle:
Natriuretic Peptides (BNP)
Cardiac myocytes produce these hormones in response to ventricular stretching...
39